Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TBXAS1 | P24557 | 3/20 | 0.46 |
| ▸ | LMNA | P02545 | 4/20 | 0.45 |
| ▸ | MAPT | P10636 | 3/20 | 0.45 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.44 |
| ▸ | PORCN | Q9H237 | 1/20 | 0.44 |
| ▸ | PSEN1 | P49768 | 6/20 | 0.42 |
| ▸ | PSEN2 | P49810 | 6/20 | 0.42 |
| ▸ | APH1B | Q8WW43 | 6/20 | 0.42 |
| ▸ | NCSTN | Q92542 | 6/20 | 0.42 |
| ▸ | APH1A | Q96BI3 | 6/20 | 0.42 |
| ▸ | PSENEN | Q9NZ42 | 6/20 | 0.42 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22077999 | 0.84 | DYRK1A (0.46) | TBXAS1LMNAMAPTNPSR1ALDH1A1 | |
| SCHEMBL22078071 | 0.81 | PSEN1 (0.48) | TBXAS1LMNAMAPTNPSR1ALDH1A1 | |
| SCHEMBL22078072 | 0.80 | ADH5 (0.53) | TBXAS1MAPTALDH1A1HTTKDM4E | |
| SCHEMBL22078076 | 0.80 | TBXAS1 (0.53) | TBXAS1MAPTALDH1A1KDM4ECYP3A4 | |
| SCHEMBL22077255 | 0.76 | ESR1 (0.48) | TBXAS1LMNAMAPTALDH1A1KDM4E | |
| SCHEMBL24439861 | 0.76 | PSEN1 (0.66) | MAPTALDH1A1KDM4EMEN1KMT2A | |
| SCHEMBL29606060 | 0.76 | PSEN1 (0.66) | MAPTALDH1A1KDM4EMEN1KMT2A | |
| SCHEMBL16126788 | 0.74 | CYP11B1 (0.53) | LMNAMAPTALDH1A1HTTKDM4E | |
| SCHEMBL22078080 | 0.74 | ADH5 (0.46) | TBXAS1HTTCYP3A4 | |
| SCHEMBL22077986 | 0.72 | ADH5 (0.44) | TBXAS1HTTCYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11655244-B2 | Carbazole compounds and methods of use thereof | GSNO THERAPEUTICS, INC. (US) | 2023-05-23 | — | — | US | disclosed |
| US-20200181129-A1 | CARBAZOLE COMPOUNDS AND METHODS OF USE THEREOF | GSNO THERAPEUTICS, INC. | 2020-06-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11655244-B2 | Carbazole compounds and methods of use thereof | GSR, CBR3, CBR1 | TBXAS1 1031/4885LMNA 3505/4885MAPT 4280/4885 |
| US-20200181129-A1 | CARBAZOLE COMPOUNDS AND METHODS OF USE THEREOF | GSR, CBR3, CBR1 | TBXAS1 1031/4885LMNA 3505/4885MAPT 4280/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.